NIAID Site Search

By studying the rare disease APECED, NIAID researchers and colleagues uncovered an unexpected immune mechanism that promotes susceptibility to fungal infections of the mucous membranes. Their findings suggest potential therapies for people with APECED and pave the way for work to investigate these tissue-specific immune responses in other diseases.

Last Reviewed: January 14, 2021

NIAID requires your human subjects research plans to include women, minorities, and participants of all ages unless you can justify their exclusion.

Last Reviewed: January 24, 2022

Sample application from David Al-Adra MD, Ph.D., for NIH standard independent research project grant (K08).

Last Reviewed: September 13, 2024

Last Reviewed: August 6, 2024

Office of Research on Women’s Health and NIH Support for Research on Women’s Health Report of the Advisory Committee on Research on Women’s Health: Fiscal Years 2019–2020 508-compliant PDF

Last Reviewed: March 8, 2022

Jordan Report: Accelerated Development of Vaccines (2002) from NIAID includes updates on vaccine research for specific infectious diseases.

Last Reviewed: December 31, 2002

Sample application from Mohammad Ayoub Mir

Last Reviewed: August 4, 2017

NIH Opening Statement Senate LHHS FY 2019 Hearing: Prepared statement of Lawrence A. Tabak, D.D.S., PH.D., Principal Deputy Director, Office of the Director

Last Reviewed: August 16, 2018

This document outlines the guidelines for the diagnosis and management of food allergy in the US, specifically for patients, families, and caregivers.

Last Reviewed: July 9, 2019

On this 35 th World AIDS Day, the National Institutes of Health (NIH) joins its partners in honoring the lives lost due to the HIV pandemic. For decades, this virus has exacted a tragic toll, affecting people, families, and communities worldwide, threatening social and economic development, and exacerbating stigma, often toward people who already experience discrimination and health disparities

Published: December 1, 2023

The 203 rd meeting of the National Advisory Allergy and Infectious Diseases Council (NAAIDC) convened virtually at 10:30 a.m. on Monday, January 30, 2023. Dr. Hugh Auchincloss, Acting Director, National Institute of Allergy and Infectious Diseases (NIAID) presided as chair. In accordance with the provisions of Public Law 92-463, the meeting was open to the public from 10:30 a.m. to 11:51 a.m. and

Last Reviewed: February 5, 2024

The 205 th meeting of the National Advisory Allergy and Infectious Diseases Council (NAAIDC) convened at 5601 Fishers Lane in the Grand Hall at 10:30 a.m. on Monday, September 11, 2023. Dr. Hugh Auchincloss, Acting Director, National Institute of Allergy and Infectious Diseases (NIAID) presided as chair. In accordance with the provisions of Public Law 92-463, the meeting was open to the public

Last Reviewed: January 11, 2024